|
ZNF529 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.222800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.881200E-01 |
| Normal-vs-Stage2 |
4.410400E-01 |
| Normal-vs-Stage3 |
8.618100E-02 |
| Normal-vs-Stage4 |
5.608200E-01 |
| Stage1-vs-Stage2 |
5.839400E-01 |
| Stage1-vs-Stage3 |
3.930200E-02 |
| Stage1-vs-Stage4 |
6.480800E-01 |
| Stage2-vs-Stage3 |
1.413790E-01 |
| Stage2-vs-Stage4 |
8.800200E-01 |
| Stage3-vs-Stage4 |
3.252200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.310200E-01 |
| Normal-vs-AfricanAmerican |
2.015600E-01 |
| Normal-vs-Asian |
7.327000E-01 |
| Caucasian-vs-AfricanAmerican |
3.999200E-01 |
| Caucasian-vs-Asian |
6.777600E-01 |
| AfricanAmerican-vs-Asian |
5.192400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.101600E-01 |
| Normal-vs-Female |
1.883180E-01 |
| Male-vs-Female |
3.292000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.135800E-01 |
| Normal-vs-Extreme_Weight |
7.571600E-01 |
| Normal-vs-Obese |
2.003600E-01 |
| Normal-vs-Extreme_Obese |
8.212400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.274000E-01 |
| Normal_Weight-vs-Obese |
9.752600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.810000E-01 |
| Extreme_Weight-vs-Obese |
1.241030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.361800E-01 |
| Obese-vs-Extreme_Obese |
6.335600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.106800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.669700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.364200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.405700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.065200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.264200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.456400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.128000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.483700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.542560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.234100E-02 |
| Normal-VS-Type2 PRCC |
6.570500E-02 |
| Normal-VS-KIRP CIMP |
6.879200E-01 |
| Normal-VS-Unclassified PRCC |
6.234400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.34510000000677E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.695600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.562800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.189200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.418000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.481600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.988200E-01 |
| Normal-vs-N1 |
4.839200E-01 |
| Normal-vs-N2 |
4.561800E-02 |
| N0-vs-N1 |
3.640000E-01 |
| N0-vs-N2 |
2.693800E-01 |
| N1-vs-N2 |
3.324800E-01 |
|
|
